Reporter covering health and medicineEducation: Syracuse University, BS in journalismLaurie McGinley covers health and medicine for The Washington Post. She focuses on the Food and Drug Administration as well as cancer research and treatment. She was previously The Post's health, science and environment editor.Honors & Awards:
Part of Wall Street Journal team that won the 1997 Pulitzer Prize for national reporting on AIDS
Professional Affiliations: Association of Health Care Journalists
Now, that the Food and Drug Administration has cleared the first coronavirus vaccine for emergency use in children as young as 12, families are sure to have questions about the Pfizer-BioNTech shot and when it will become available.
The action has been urgently sought by tobacco opponents and civil rights groups who say African Americans have been disproportionately hurt by the industry’s aggressive targeting of Black communities.
The position would be similar to one taken by Europe’s drug regulator, the European Medicines Agency, which said this week the Johnson & Johnson vaccine should carry a warning but placed no restrictions on its use.
Johnson & Johnson has grappled with vaccine manufacturing delays associated with production at the Emergent plant in Baltimore.
Apr 1, 2021
About Laurie McGinley
Laurie McGinley covers health and medicine for The Washington Post. She focuses on the Food and Drug Administration as well as cancer research and treatment. She was previously The Post's health, science and environment editor.